Clinical Trial Update: A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)

View source ↗

Summary

A post-marketing surveillance study evaluating doxazosin mesylate GITS in Filipino patients with benign prostatic hyperplasia has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Doxazosin mesylate GITS (doxazosin mesylate)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Prostatic Hyperplasia | Status: COMPLETED | Results posted: 2011-10-28